Unknown

Dataset Information

0

LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma.


ABSTRACT: Decreased renal cell cancer-related mortality is an important societal goal, embodied by efforts to develop effective biomarkers enabling early detection and increasing the likelihood of curative treatment. Herein, we sought to develop a new biomarker for early and minimally invasive detection of renal cell carcinoma (RCC) based on a microRNA panel assessed by ddPCR. Plasma samples from patients with RCC (n = 124) or oncocytomas (n = 15), and 64 healthy donors, were selected. Hsa-miR-21-5p, hsa-miR-126-3p, hsa-miR-155-5p and hsa-miR-200b-3p levels were evaluated using a ddPCR protocol. RCC patients disclosed significantly higher circulating levels of hsa-miR-155-5p compared to healthy donors, whereas the opposite was observed for hsa-miR-21-5p levels. Furthermore, hsa-miR-21-5p and hsa-miR-155-5p panels detected RCC with high sensitivity (82.66%) and accuracy (71.89%). The hsa-miR-126-3p/hsa-miR-200b-3p panel identified the most common RCC subtype (clear cell, ccRCC) with 74.78% sensitivity. Variable combinations of plasma miR levels assessed by ddPCR enable accurate detection of RCC in general, and of ccRCC. These findings, if confirmed in larger studies, provide evidence for a novel ancillary tool which might aid in early detection of RCC.

SUBMITTER: Sequeira JP 

PROVIDER: S-EPMC8869982 | biostudies-literature | 2022 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

LiKidMiRs: A ddPCR-Based Panel of 4 Circulating miRNAs for Detection of Renal Cell Carcinoma.

Sequeira José Pedro JP   Constâncio Vera V   Salta Sofia S   Lobo João J   Barros-Silva Daniela D   Carvalho-Maia Carina C   Rodrigues Jéssica J   Braga Isaac I   Henrique Rui R   Jerónimo Carmen C  

Cancers 20220209 4


<h4>Background</h4>Decreased renal cell cancer-related mortality is an important societal goal, embodied by efforts to develop effective biomarkers enabling early detection and increasing the likelihood of curative treatment. Herein, we sought to develop a new biomarker for early and minimally invasive detection of renal cell carcinoma (RCC) based on a microRNA panel assessed by ddPCR.<h4>Methods</h4>Plasma samples from patients with RCC (<i>n</i> = 124) or oncocytomas (<i>n</i> = 15), and 64 he  ...[more]

Similar Datasets

| S-EPMC10531069 | biostudies-literature
| S-EPMC7718885 | biostudies-literature
| S-EPMC5154588 | biostudies-literature
2020-08-03 | GSE113740 | GEO
| S-EPMC9615554 | biostudies-literature
| S-EPMC5630422 | biostudies-literature
| S-EPMC4839694 | biostudies-literature
| S-EPMC6998103 | biostudies-literature
| S-EPMC8353948 | biostudies-literature
| S-EPMC6164661 | biostudies-other